Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 12—December 2025
Research Letter
Macrolide-Resistant Mycoplasma pneumoniae in Children, Ohio, USA
Figure

Figure. Monthly azithromycin prescriptions per 1,000 patients at Nationwide Children’s Hospital urgent care centers, Mycoplasma pneumoniae positive rates, and MRMp rates, Ohio, USA, September 2023–May 2025. Macrolide resistance was determined in a subset of samples. MRMp rates were not available during September 2023–December 2023. MRMp, macrolide-resistant M. pneumoniae.
Page created: December 11, 2025
Page updated: December 24, 2025
Page reviewed: December 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.